Sojitz Corporation’s Post

🔬 Shaping China's Synthetic Biology Future! Discover cutting-edge insights in Newsbreak's latest report: “Exploring the Cutting-Edge Innovations in China's Synthetic Biology: A Closer Look at SBS Genetech”. Join us in exploring the forefront of biotechnology innovation and shaping tomorrow together! #SBSGenetech #syntheticbiology 🚀

Today we’ve entered into a binding definitive agreement with Sojitz Corporation to bring more synthetic biology R&D services to Japan! Sojitz intends to use its extensive network to help Ginkgo foster business connections within the Japanese bioeconomy. The Japanese government has formulated a Bioeconomy Strategy that envisions a $837 billion (USD) bioeconomy. We hope to apply our platform in support of the Japanese biotech ecosystem to accelerate progress to achieving this vision. Find out more: https://hubs.la/Q02x6s3z0

Join me on May 7th from 2:45 - 3:30 pm for a session entitled "Commercialization Unlocked: How to Overcome Synbio's Core Scale-Up and Manufacturing Challenges." Alongside industry experts Hendrik Waegeman, Fiona Mischel, and Aletta Schnizler, we'll discuss strategies to unlock the full potential of synthetic biology in commercialization - Tons 'r' Us!  

🔬 The XXVII Enzyme Engineering Conference is the leading international forum for discussion of enzyme engineering technology and applications. It was indeed a moment of honour and joy to have our CTO and Co-founder, Dr. Akbar Vahidi,  as a panelist during the conference. He talked about how our technology is one of its kind, to fundamentally transform the enzyme discovery and enzyme engineering process. ✨ We were delighted to have Prof.Uwe Bornscheuer, Vesna Mitchell and David Schönauer  join the panel discussion on the expansion and difficulties in the field. It is quite amazing to meet brilliant minds from academia and industry from world over, coming together to discuss enzyme engineering here in #Singapore, a key hub of the global #biotech ecosystem. 🚀 At Allozymes, we utilize our advanced #ultra-high throughput #microfluidics platform and #machinelearning capabilities to accelerate enzyme evolution. We feel inspired by all recent discussions and discoveries in the field and renew our dedication to transform the enzyme engineering process for a brighter, sustainable future. #enzymeengineering #Singapore #Allozymes #inspiration #innovation #sustainable #ecosystem

Did you know that government grants like STTR and SBIR are the largest sources of funding for early-stage life science startups? These grants are an essential tool for so many, but they also come with some serious strings attached. Learn more in the most recent edition of MichBio's BioMatters Magazine.

Before we get swept away with what's shaping up to be a great summer, be sure to check out the Spring edition of MichBio's BioMatters magazine 😎. This is an INCREDIBLE publication that showcases Michigan's booming biosciences industry. Aurora Patents was honored to be featured in this edition with a piece on Government Grants (SBIR/STTR) and Patent rights. On pages 28-29 in the link below, we write about not only how valuable and necessary these grants are for so many startups, particularly for those in biotech, but also the strings recipients need to be aware of when it comes to things like: ⦿ Fully paid-up, irrevocable licenses for Federal Government (and subcontractor!) usage. ⦿ Sticky implications for licensing when using your own subcontractors instead of W2 employees. ⦿ How march-in rights currently factor into government use and dangerous provisions currently being considered by the government. ⦿ Losing your ownership rights for failing to commercialize or file the correct paperwork on time. #patents #lifesciece #biotech #sbir #sttr #governmentgrants #BayhDole #research #grants #medtech #startups #funding #licensing #invention #biosciences #michiganeconomy #science #ip https://lnkd.in/gcsGzjXn

It's ridiculous to expect that scientists should spend most of their time on grant applications rather than research 🔬 This is why DeSci matters ✨ Through Decentralized Science, we can begin to truly focus on enhancing scientific freedom and global collaboration 🌐 DeSci is already in the process of transforming key scientific verticals, such as: 💰 R&D funding through DAOs 📚 Publishing ⚗️ Reproducibility 🎖️ Identity & Reputation This is only the beginning — there is an entire world of scientific possibility that comes with DeSci! Together, we can create a future where science is boundless and innovation is abundant! 🌍 Say yes to DeSci. Say yes to BIO. Say yes to bio/acc. https://www.bio.xyz/

🧬The DNA Process Development and Manufacturing 2024 is here! Syngoi team will participate in one of the world's most important conferences on DNA process manufacturing in #Boston. ➡️On Wednesday 6th at 12:30h we will give a lecture on the potential of synthetic methods for faster production of high quality DNA. We are waiting for you! Come and discover the latest technology in synthetic DNA. #DNA #celltherapy #biotech #manufacturingDNA #chemicalbiology

Next up in our #MeetTheTeam series is a fascinating Q&A with Pavel Aronov, Senior Director, Bioanalytics. Pavel’s journey included stops at Stanford’s mass spectrometry lab and multiple food startups before he joined Antheia. His team focuses on analytical chemistry, which involves understanding the quantitative composition of matter. Key questions that Pavel answers include: are we making the right product, is it pure enough, and is the measurement accurate? This work plays a crucial role in our commercial strategy as we scale up production of our biosynthetic KSMs and APIs. Read more about Pavel’s work and what drew him to Antheia: https://bit.ly/3KqABfw #Antheia #PharmaSupplyChain #Bioanalytics #SyntheticBiology

Here is an excellent article by Michael Clay outlining the challenges and opportunities in synthetic biology. Commercializing synbio based products is a hard and rewarding journey. In addition to having the product-market fit and the right technology to deliver the product, it is absolutely critical to have the right teams working together as one lean unit- from R&D to manufacturing to business. If we are thoughtful about the inherent challenges, we can be bold in pursuing ambitious goals. My summary statement: Learn from the past, Imagine the future. Thanks for the writeup Mike! https://lnkd.in/gb2aWNqG